By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company OptimizeRx Corp.

OptimizeRx Corp. (OPRX)

NASDAQ Currency in USD
$379.00
+$4.33
+1.16%
Last Update: 18 Jul 2026, 15:25
$7.03bn
Market Cap
1.07k
P/E Ratio (TTM)
Forward Dividend Yield
$274.64-$525.30
52 Week Range

OPRX Stock Price Chart

Explore OptimizeRx Corp. interactive price chart. Choose custom timeframes to analyze OPRX price movements and trends.

OPRX Company Profile

Discover essential business fundamentals and corporate details for OptimizeRx Corp. (OPRX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

IPO Date

28 Nov 2007

Employees

136.00

CEO

Stephen L. Silvestro

Description

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

OPRX Financial Timeline

Browse a chronological timeline of OptimizeRx Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Aug 2026

EPS estimate is $0.11, while revenue estimate is $20.20m.

Earnings released on 12 May 2026

EPS came in at $0.14 surpassing the estimated $0.01 by +1.30k%, while revenue for the quarter reached $19.84m , beating expectations by +5.90%.

Earnings released on 5 Mar 2026

EPS came in at $0.51 surpassing the estimated $0.23 by +121.74%, while revenue for the quarter reached $32.24m , beating expectations by +4.28%.

Earnings released on 6 Nov 2025

EPS came in at $0.20 surpassing the estimated $0.03 by +566.67%, while revenue for the quarter reached $26.07m , missing expectations by -15.68%.

Earnings released on 7 Aug 2025

EPS came in at $0.24 surpassing the estimated $0.03 by +700.00%, while revenue for the quarter reached $29.20m , beating expectations by +22.50%.

Earnings released on 12 May 2025

EPS came in at $0.08 surpassing the estimated -$0.11 by +172.73%, while revenue for the quarter reached $21.93m , beating expectations by +17.35%.

Earnings released on 12 Mar 2025

EPS came in at $0.30 surpassing the estimated $0.25 by +20.00%, while revenue for the quarter reached $32.32m , beating expectations by +72.09%.

Earnings released on 13 Nov 2024

EPS came in at $0.12 surpassing the estimated $0.06 by +100.00%, while revenue for the quarter reached $21.31m , missing expectations by -29.37%.

Earnings released on 8 Aug 2024

EPS came in at $0.02 surpassing the estimated -$0.07 by +128.57%, while revenue for the quarter reached $18.81m , missing expectations by -6.83%.

Earnings released on 14 May 2024

EPS came in at -$0.11 matching the estimated -$0.11, while revenue for the quarter reached $19.69m , beating expectations by +8.60%.

Earnings released on 28 Mar 2024

EPS came in at $0.26 falling short of the estimated $0.32 by -18.75%, while revenue for the quarter reached $28.37m , beating expectations by +7.17%.

Earnings released on 6 Nov 2023

EPS came in at $0.09 surpassing the estimated $0.03 by +260.00%, while revenue for the quarter reached $16.33m , beating expectations by +7.37%.

Earnings released on 14 Aug 2023

EPS came in at -$0.01 falling short of the estimated -$0.01 by -53.37%, while revenue for the quarter reached $13.82m , missing expectations by -6.70%.

Earnings released on 10 May 2023

EPS came in at -$0.09 falling short of the estimated -$0.08 by -12.50%, while revenue for the quarter reached $13.00m , beating expectations by +5.29%.

Earnings released on 8 Mar 2023

EPS came in at $0.25 surpassing the estimated $0.24 by +4.17%, while revenue for the quarter reached $19.65m , missing expectations by -9.72%.

Earnings released on 8 Nov 2022

EPS came in at $0.07 surpassing the estimated $0.04 by +90.68%, while revenue for the quarter reached $15.09m , beating expectations by +1.13%.

Earnings released on 9 Aug 2022

EPS came in at $0.04 falling short of the estimated $0.10 by -60.00%, while revenue for the quarter reached $13.98m , missing expectations by -18.08%.

Earnings released on 4 May 2022

EPS came in at -$0.01 falling short of the estimated -$0.01 by -15.21%, while revenue for the quarter reached $13.73m , beating expectations by +1.37%.

Earnings released on 24 Feb 2022

EPS came in at $0.22 surpassing the estimated $0.18 by +22.22%, while revenue for the quarter reached $20.31m , beating expectations by +0.76%.

Earnings released on 9 Nov 2021

EPS came in at $0.09 falling short of the estimated $0.13 by -30.77%, while revenue for the quarter reached $16.12m , beating expectations by +7.43%.

Earnings released on 4 Aug 2021

EPS came in at $0.10 surpassing the estimated $0.07 by +42.86%, while revenue for the quarter reached $13.63m , beating expectations by +9.44%.

OPRX Stock Performance

Access detailed OPRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run